LUCIDITY phase 3 topline data presented at CTAD for HMTM - the only oral anti-Tau therapy in late-stage development

/PRNewswire/ -- TauRx Pharmaceuticals Ltd is a global leader in Tau-based research in Alzheimer's disease (AD), being the only company running late-stage...

Related Keywords

China ,Canada ,United Kingdom ,Singapore ,San Francisco ,California ,United States ,Scotland ,George Grossberg ,St Louis University School Of Medicine ,University Of Aberdeen ,Taurx Pharmaceuticals Ltd ,Clinical Trials ,Director Division ,Geriatric Psychiatry Department ,Behavioural Neuroscience ,